India: Pfizer’s TM Suit Not Entertained: Lack Of Territorial Jurisdiction.

Last Updated: 10 March 2009

Jurisdiction being the most vital consideration while instituting a suit, the Lack of Jurisdiction is one of the first and vital contentions raised, as a ground for suits to be dismissed. The present matter of Pfizer Enterprises v. Dr. H.R. Manchanda 2009 (39) PTC 114 (Del.) dismissed Pfizer's plea with respect to the Delhi High Court's jurisdiction over the matter owing to lack of territorial jurisdiction. The suit deals with the infringement of a trademark as well as with passing off offence being committed by Dr. H.R. Manchanda, who averred the lack of jurisdiction in the present Court. Rendition of accounts and delivery up of goods was also prayed for by Pfizer.

Pfizer, a company organized under the laws of Luxembourg has its subsidiary, also party to the suit located in India since 1950. In addition to the large number of products available in the Indian market, 'Dalacin', a highly sought after antibiotic treats infections in different parts of the body caused by bacteria, which is the essential component of 'Dalacin C' and 'Dalacin T' is also marketed. It was stated that 'Dalacin C' was first adopted by the Upjohn Company in 1968 in India; (whose name was later changed to Pharmacia and Upjohn Company in 1996) and the mark later assigned to Pharmacia Enterprises SA in 2002, was subsequently renamed Pfizer Enterprises SARL, the first plaintiff.

The mark was averred to be fanciful and coined word with no denotative meaning being distinctive in nature. By virtue of priority in adoption, continuous and extensive use, and widespread advertisement, Pfizer was said to be the proprietor of the marks. However, both 'Dalacin C' and 'Dalacin T' are registered in India, Pfizer' subsidiary being the authorized user of the same. They aver that due to the extensive use and the reputation of Pfizer, the marks are exclusively identified with them.

'Clindamycin' the active ingredient in Dalacin is also manufactured by Pfizer's Indian subsidiary. Pfizer stated that they were shocked when they discovered from the website of the Defendants that they offered pharmaceutical compositions Clindamycin hydrochloride and Clindamycin phosphate under the mark 'Dalcinex', in capsule as well as injections form, just as Pfizer did. Pfizer alleged that use of the mark Dalcinex amounted to infringement and their attempt to dishonestly appropriate the goodwill amounted to passing off. The marks being phonetically and visually similar and put to use in relation to an identical product and therefore, would cause confusion in the minds of the public

Pfizer on the question of jurisdiction submitted that by virtue of Section 134(1) of the Trade Marks Act, 1999 Pfizer' and Dr. Manchanda' products being available for sale in Delhi. Dr. Manchanda and his co-parties however averred that none of the plaintiffs were registered proprietors of the trademarks within the meaning of section 2(i)(v) of the Act and hence no suit for infringement was maintainable. They also alleged the assignment deeds to be invalid and unreliable and that the registration of the mark Dalcinex which is pending since their year of manufacture 2004.

On the question of jurisdiction, Dr. Manchanda' counsel contended that the suit was not maintainable in this Court, since both the parties carried on business outside the jurisdiction of the Delhi High Court. It was further stated that no documentary evidence to support the availability of the product within the jurisdiction of this Court had been submitted. He also drew the attention of this Court to the fact that Pfizer had not averred or produced any document as to how Dr. Manchanda' product including the packaging has been procured in Delhi. It was submitted that the suit ought to be filed either in the place where the defendant resides and carries on business or the place at which the cause of action arises.

As regards the invalidity of the assignment deed, the same was said to be insufficiently stamped and invalid under section 45 of the 1999 Act. It was also submitted that copies of the certificates of renewal of trademark from the year 1982 did not bear the name of the proprietor on them. Pfizer was also stated to have insufficiently established the ingredients for an action of passing off. The Counsel also submitted that the mark had been coined using the alphabets of the generic salt, or ingredient and that no exclusive right could be asserted.

The Counsel contended that the sale of Dr. Manchanda' goods is something that cannot be denied. And that it was inconceivable that no business took place within the jurisdiction of this Court. The counsel for Pfizer relied upon the documents filed and submitted that the defendants are marketing their products and advertising through the Internet. It was submitted that the website can be accessed from Delhi and thus, this Court possesses jurisdiction. The Court stated that they needed to go through the contents of the plaint to decide whether the suit discloses a triable cause of action, and whether this court had jurisdiction or not.

The Court took into consideration Section 20 of the Code of Civil Procedure, 1908, Section 62(2) of the Copyright Act, 1957 and section 134 of the Trade Marks Act, 1999, for the adjudication of trademark disputes. They noted that the plaint showed that both the Indian Subsidiary of Pfizer and co-defendant had r offices in Mumbai and undeniably carry on their business in Mumbai too. However the plaint did not disclose either of them having their office in Delhi.

The Court noted that Pfizer was far from establishing neither that the defendants carried out the essential parts of their business from Delhi nor that their goods were in fact sold in Delhi. And that the allegation, therefore, that Pfizer has become aware of the infringing activities of the defendant, within territorial jurisdiction of this court, or that any cause of action arose within jurisdiction, are not even prima facie substantiated. Further, the Court stated that there is no purposeful direction of the web activities to the concerned geographical locale, in this case Delhi, to prima facie establish this Court's jurisdiction. The plaint was returned on account of clear lack of territorial jurisdiction.

© Lex Orbis 2009

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

In association with
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.